DPHARMA Stock Forum

Good morning mooers! Here are things you need to know about today's market:
●US Stocks Take a Breather as Investors Await Key Jobs Data
●Sunway Included in FTSE Bursa Malaysia KLCI as AMMB Holdings is Demoted
●Malaysian Property Market Shows Significant Growth and Resilience, Says Housing Minister
●Stocks to watch: Sime Darby Property, Nestcon
-moomoo News MY
Wall Street Summary
US stocks took a ...

TA Research predicts a recovery in Duopharma's CHC segment and increased sales to the government sector in 2024. They also foresee higher volumes and pricing from the new APPL contract, and a rise in the Insulin contract contribution to RM90mil in FY24.

TA Research expects growth in Duopharma's sales in 2024 due to APPL contract and resurgence in consumer health. Despite 3Q23 results, RHB Research also retains 'buy' call, noting the brand's potential growth from investments in high-value sectors like oncology and biosimilars.

Good morning mooers! Here are things you need to know about today's market:
●Wall Street flat as investors eye rates movement
●EPF allocates RM97bil for local market
●PayNet on track to contribute to tourism growth
●Anwar: Govt dedicated to facilitating EV industry growth
●Stocks to watch: F&N
-moomoo News MY
Wall Street Summary
U.S. stocks began to pull back from their winning streaks while 10-year yields dropped around 4...

Good morning mooers! Here are things you need to know about today's market:
●US stocks surge to close higher on Tuesday, powered by upbeat earnings and guidance
●Bursa still has potential to rally into year-end
●Budget 2024 to boost corporate bond market - Franklin Templeton
●Transport sector to sustain prospects on high demand
●Lower CPO output in 2024 likely to lift price sentiment
●Stocks to watch: Frontken, LPI C...